FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Levomepromazine 6mg tablets (DE Pharmaceuticals) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oral Impact oral powder 74g sachets (Flavour Not Specified) 5 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ascorbic acid 1g / Zinc citrate 10mg effervescent tablets sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium carbonate 1.25g / Colecalciferol 10microgram chewable tablets sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Memantine 10mg soluble tablets sugar free VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Memantine 20mg soluble tablets sugar free VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Memantine 10mg soluble tablets sugar free (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ascorbic acid 1g / Zinc citrate 10mg effervescent tablets sugar free 20 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Alzhok 10mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Memantine 10mg soluble tablets sugar free 28 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Redoxon Double Action Vitamin C and Zinc effervescent tablets orange (Bayer Plc) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Alzhok 20mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Valsartan 80mg tablets (DE Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Redoxon Double Action Vitamin C and Zinc effervescent tablets (Bayer Plc) 15 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Memantine 20mg soluble tablets sugar free (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Colecalciferol 400unit / Calcium carbonate 1.25g chewable tablets sugar free 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Memantine 20mg soluble tablets sugar free (Zentiva Pharma UK Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Memantine 20mg soluble tablets sugar free 28 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Redoxon Double Action Vitamin C and Zinc effervescent tablets orange (Bayer Plc) 15 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Alzhok 10mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
A1-Cal D3 500mg/400unit chewable tablets (TriOn Pharma Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Alzhok 20mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 7 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Memantine 20mg soluble tablets sugar free 7 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Memantine 10mg soluble tablets sugar free (Zentiva Pharma UK Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Cubicole Vitamin C+Z effervescent tablets (Cubic Pharmaceuticals Ltd) 20 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ascorbic acid 1g / Zinc citrate 10mg effervescent tablets sugar free 15 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Memantine 10mg soluble tablets sugar free 7 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ascorbic acid 1g / Zinc citrate 10mg effervescent tablets sugar free 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
A1-Cal D3 500mg/400unit chewable tablets (TriOn Pharma Ltd) 60 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium carbonate 1.25g / Colecalciferol 10microgram chewable tablets sugar free 60 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cubicole Vitamin C+Z effervescent tablets (Cubic Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Redoxon Double Action Vitamin C and Zinc effervescent tablets orange (Bayer Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Alzhok 20mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Valsartan 80mg tablets (DE Pharmaceuticals) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Redoxon Double Action Vitamin C and Zinc effervescent tablets (Bayer Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Alzhok 10mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 7 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Calceos chewable tablets (Provalis Healthcare Ltd) 60 tablet 4 tubes of 15 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
A1-Cal D3 500mg/400unit chewable tablets (TriOn Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calceos chewable tablets (Provalis Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely deflazacort 6 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Sofradex eye/ear drops VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Deflazacort 6mg tablets 60 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sofradex ear/eye drops (Mawdsley-Brooks & Company Ltd) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcort 6mg tablets (Lexon (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sofradex eye/ear drops (Florizel Ltd) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcort 6mg tablets (Neon Healthcare Ltd) 60 tablet 6 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Sofradex eye/ear drops 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcort 6mg tablets (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcort 6mg tablets (Waymade Healthcare Plc) 60 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Sofradex ear/eye drops 8 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcort 6mg tablets (Lexon (UK) Ltd) 60 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sofradex eye/ear drops (Florizel Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sofradex ear/eye drops (Sanofi) 8 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sofradex ear/eye drops (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcort 6mg tablets (Neon Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zavedos 10mg/10ml solution for injection vials (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Betamethasone valerate 2.25mg medicated plasters 8 plaster VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zavedos 5mg/5ml solution for injection vials (Pfizer Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zavedos 5mg/5ml solution for injection vials (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zavedos 10mg/10ml solution for injection vials (Pfizer Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Betesil 2.25mg medicated plasters (Derma UK Ltd) 8 plaster VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ultrasun Sports gel SPF 30 (Ultrasun UK Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely mitomycin 10 milligram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mitomycin-C Kyowa 10mg powder for solution for injection vials (Kyowa Hakko) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mitomycin 10mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mitomycin-C 10mg powder for solution for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mitomycin-C Kyowa 10mg powder for solution for injection vials (Kyowa Hakko) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-codamol 15mg/500mg effervescent tablets sugar free (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mitomycin 10mg powder for solution for injection vials (A A H Pharmaceuticals Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mitomycin 10mg powder for solution for injection vials (Accord Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mitomycin 10mg powder for solution for injection vials (Accord Healthcare Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-codamol 15mg/500mg effervescent tablets sugar free (A A H Pharmaceuticals Ltd) 100 tablet 10 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nifedipine 10mg capsules (DE Pharmaceuticals) 90 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Ultrasun Sports gel SPF 30 400 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Qlaira tablets (Bayer Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 200mg/20ml solution for injection vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Bristol Laboratories Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Olive oil 20% / Compound benzoin tincture 3% in Compound zinc paste 1 gram VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Qlaira tablets (Bayer Plc) 84 tablet 3 x (2 + 2 + 2 + 17 + 5 tabs) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Olive oil 20% / Compound benzoin tincture 3% in Compound zinc paste (Special Order) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ultrasun Sports gel SPF 30 (Ultrasun UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Ultrasun Sports gel SPF 30 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Bristol Laboratories Ltd) 28 capsule 4 x 7 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ultrasun Sports gel SPF 50 (Ultrasun UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 75micrograms/hour transdermal patches (Pilsco Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 50micrograms/hour transdermal patches (Pilsco Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 25micrograms/hour transdermal patches (Pilsco Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Ethigen Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (A A H Pharmaceuticals Ltd) 30 tablet 2 x 15 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 100micrograms/hour transdermal patches (Pilsco Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema (CST Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 75micrograms/hour transdermal patches (Pilsco Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Matrifen 25micrograms/hour transdermal patches (Pilsco Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Ethigen Ltd) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nifedipine 5mg capsules (CST Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nifedipine 5mg capsules (CST Pharma Ltd) 90 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema (CST Pharma Ltd) 14 dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nifedipine 5mg capsules (CST Pharma Ltd) 84 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 50micrograms/hour transdermal patches (Pilsco Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 25micrograms/hour transdermal patches (Pilsco Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Page 2 of 86 Next End

This concept is not in any reference sets

Back to Start